Exhibit 99.2

 

Financial Information for the Three Months and Six Months Ended June 30, 2026 and 2025 of Kenon and OPC and

 

Reconciliation of Certain non-IFRS Financial Information

 

Table of Contents

 

Appendix A: Summary of Kenon’s consolidated financial information

 

Appendix B: Summary of OPC’s consolidated financial information

 

Appendix C: Definition of OPC’s Adjusted EBITDA and non-IFRS reconciliation

 

 

 

Appendix A

 

Summary Kenon consolidated financial information

 

Kenon Holdings Ltd. and its subsidiaries
Consolidated Statements of Financial Position (Unaudited)

 

   June 30,   December 31, 
   2026   2025 
   $ millions 
Current assets          
Cash and cash equivalents   1,695    1,478 
Trade receivables   186    137 
Short-term derivative instruments   1    16 
Other investments   78    107 
Other current assets   58    65 
Total current assets   2,018    1,803 
Non-current assets          
Investment in OPC’s associated companies   1,015    1,626 
Long-term restricted cash   187    164 
Long-term derivative instruments   57    13 
Deferred taxes, net   28    10 
Property, plant and equipment, net   3,479    1,372 
Intangible assets, net   89    83 
Long-term prepaid expenses and other non-current assets   32    108 
Right-of-use assets, net   342    201 
Total non-current assets   5,229    

3,577

 
Total assets   7,247    5,380 
Current liabilities          
Current maturities of loans from banks and others   204    117 
Trade and other payables   318    245 
Short-term derivative instruments   73    - 
Current maturities of lease liabilities   17    3 
Current tax liabilities   14    - 
Total current liabilities   626    365 
Non-current liabilities          
Long-term loans from banks and others   2,324    1,142 
Debentures   449    510 
Deferred taxes, net   178    162 
Other non-current liabilities   62    8 
Long-term derivative instruments   49    - 
Long-term lease liabilities   159    8 
Total non-current liabilities   3,221    

1,830

 
Total liabilities   3,847    2,195 
Equity          
Share capital   50    50 
Translation reserve   62    36 
Capital reserve   32    48 
Accumulated profit   1,416    1,455 
Equity attributable to owners of the Company   1,560    1,589 
Non-controlling interests   1,840    1,596 
Total equity   3,400    3,185 
Total liabilities and equity   7,247    5,380 

 

2 

 

Kenon Holdings Ltd. and its subsidiaries
Consolidated Statements of Profit or Loss (Unaudited)

 

  

For the six months

ended June 30,

  

For the three months

ended June 30,

 
   2026   2025   2026   2025 
   $ millions   $ millions 
Revenue   696    378    379    196 
Cost of sales and services (excluding depreciation and amortization)   (510)   (289)   (265)   (150)
Depreciation and amortization   (55)   (33)   (30)   (17)
Gross profit   131    56    84    29 
Selling, general and administrative expenses   (53)   (48)   (27)   (31)
Other expenses, net   (38)   (1)   (21)   - 
Operating profit/(loss)   40    7    36    (2)
Financing expenses   (63)   (45)   (32)   (21)
Financing income   96    22    59    9 
Financing income/(expenses), net   33    (23)   27    (12)
Share of profit of OPC’s associated companies, net   38    59    4    21 
Profit before income taxes   111    43    67    7 
Income tax expense   (23)   (10)   (13)   (1)
Profit for the period   88    33    54    6 
Attributable to:                    
Kenon’s shareholders   70    17    44    5 
Non-controlling interests   18    16    10    1 
Profit for the period   88    33    54    6 
                     
Basic/diluted profit per share attributable to Kenon’s shareholders (in dollars):                    
Basic/diluted profit per share   1.34    0.32    0.85    0.10 

 

3 

 

Kenon Holdings Ltd. and its subsidiaries
Consolidated Statements of Cash Flows (Unaudited)

 

  

For the six months ended

June 30,

 
   2026   2025 
   $ millions 
Cash flows from operating activities          
Profit for the period   88    33 
Adjustments:          
Depreciation and amortization   57    36 
Diesel fuel consumption   6    5 
Financing (income)/expenses, net   (33)   23 
Share of profit of associated companies, net   (38)   (59)
Share-based payments   (60)   11 
Other expenses, net   27    1 
Income tax expense   23    10 
    70    60 
Change in trade and other receivables   (47)   (37)
Change in trade and other payables   (12)   31 
Cash generated from operating activities   11    54 
Income taxes paid, net   (2)   - 
Dividends received from associate companies, net   32    27 
Net cash provided by operating activities   41    81 

 

4 

 

Kenon Holdings Ltd. and its subsidiaries
Consolidated Statements of Cash Flows (Unaudited), continued

 

  

For the six months ended

June 30,

 
   2026   2025 
   $ millions 
Cash flows from investing activities          
Short-term deposits and restricted cash, net   (1)   - 
Investment in long-term deposit, net   -    2 
Investment in associated companies, less cash acquired   (89)   (110)
Acquisition of property, plant and equipment   (418)   (38)
Acquisition of subsidiaries, less cash acquired   19    - 
Proceeds from other investments   31    31 
Proceeds from equity-accounted investee company capital distribution   32    1 
Long-term loan repayment from an equity-accounted investee company   29    - 
Interest received   36    18 
Proceeds from transactions in derivatives not for hedging, net   36    5 
Payment of transactions in derivatives for hedging, net   (1)   - 
Net cash used in investing activities   (326)   (91)
           
Cash flows from financing activities          
Repayment of long-term loans, debentures and lease liabilities   (152)   (56)
Investments of holders of non-controlling interests in the capital of a subsidiary   54    10 
Proceeds from issuance of share capital   255    143 
Proceeds from long-term loans   521    88 
Proceeds from/(repayment of) short-term loans   39    (1)
Proceeds from derivative financial instruments, net   -    5 
Dividend paid   (201)   (253)
Repurchase of own shares   -    (10)
Interest paid   (49)   (25)
Other   (8)   - 
Net cash generated from/(used in) financing activities   459    (99)
           
Increase/(decrease) in cash and cash equivalents   174    (109)
Cash and cash equivalents at beginning of the year   1,478    1,016 
Effect of exchange rate fluctuations on balances of cash and cash equivalents   43    8 
Cash and cash equivalents at end of the period   1,695    915 

 

5 

 

Information regarding reportable segments

 

Information regarding activities of the reportable segments is set forth in the following table.

 

   For the six months ended June 30, 2026 
   OPC Israel   CPV Group   Other   Consolidated Results 
   $ millions 
Revenue   384    312    -    696 
Cost of sales (excluding depreciation and amortization)   (284)   (226)   -    (510)
Depreciation and amortization    (38)   (19)   -    (57)
Financing income   12    9    75    96 
Financing expenses   (37)   (26)   -    (63)
Share of profit of associated companies   -    38    -    38 
Profit before taxes   10    32    69    111 
Income tax (expense)/benefits   (30)   17    (10)   (23)
(Loss)/profit for the period   (20)   49    59    88 

 

   For the six months ended June 30, 2025 
   OPC Israel   CPV Group   Other   Consolidated Results 
   $ millions 
Revenue   299    79    -    378 
Cost of sales (excluding depreciation and amortization)   (219)   (70)   -    (289)
Depreciation and amortization    (36)   -    -    (36)
Financing income   3    3    16    22 
Financing expenses   (19)   (20)   (6)   (45)
Share of profit of associated companies        59         59 
Profit before taxes   17    17    9    43 
Income tax (expense)/benefits   (9)   2    (3)   (10)
Profit for the period   8    19    6    33 
                     

 

   For the three months ended June 30, 2026 
   OPC Israel   CPV Group   Other   Consolidated Results 
   $ millions 
Revenue   203    176    -    379 
Cost of sales (excluding depreciation and amortization)   (153)   (112)   -    (265)
Depreciation and amortization    (19)   (12)   -    (31)
Financing income   7    3    49    59 
Financing expenses   (20)   (12)   -    (32)
Share of profit of associated companies   -    4    -    4 
(Loss)/profit before taxes   (1)   23    45    67 
Income tax (expense)/benefits   (24)   17    (6)   (13)
(Loss)/profit for the period   (25)   40    39    54 

 

   For the three months ended June 30, 2025 
   OPC Israel   CPV Group   Other   Consolidated Results 
   $ millions 
Revenue   153    43    -    196 
Cost of sales (excluding depreciation and amortization)   (115)   (35)   -    (150)
Depreciation and amortization    (18)   -    -    (18)
Financing income   1    2    6    9 
Financing expenses   (5)   (18)   2    (21)
Share of profit of associated companies   -    21    -    21 
Profit/(loss) before taxes   12    (11)   6    7 
Income tax (expense)/benefits   (6)   7    (2)   (1)
Profit/(loss) for the period   6    (4)   4    6 

 

6 

 

Appendix B

 

Summary of OPC consolidated financial information

 

OPC’s Consolidated Statements of Profit or Loss

 

  

For the six months

ended June 30,

  

For the three months

ended June 30,

 
   2026   2025   2026   2025 
   $ millions   $ millions 
Revenue   696    378    379    196 
Cost of sales (excluding depreciation and amortization)   (510)   (289)   (265)   (150)
Depreciation and amortization   (54)   (34)   (30)   (16)
Gross profit   132    55    84    30 
Selling, general and administrative expenses   (48)   (43)   (23)   (28)
Reclassification of the hedging reserve in respect of settled hedges to profit or loss following obtaining control over associates   (11)   -    (11)   - 
Other expenses, net   (27)   (4)   (10)   (2)
Operating profit   46    8    40    - 
Financing expenses   (63)   (39)   (32)   (23)
Financing income   21    6    10    3 
Financing expenses, net   (42)   (33)   (22)   (20)
Share of profit of associated companies, net   38    59    4    21 
Profit before income taxes   42    34    22    1 
Income tax expense   (13)   (7)   (7)   - 
Profit for the period   29    27    15    1 
                     
Attributable to:                    
Equity holders of the company   24    20    12    1 
Non-controlling interest   5    7    3    - 
Profit for the period   29    27    15    1 

 

7 

 

Summary Data from OPC’s Consolidated Statement of Cash Flows

 

  

For the six months

ended June 30,

  

For the three months

ended June 30,

 
   2026   2025   2026   2025 
   $ millions   $ millions 
Cash flows provided by operating activities   48    89    63    25 
Cash flows used in investing activities   (402)   (140)   (318)   (53)
Cash flows provided by financing activities   659    250    320    262 
Increase in cash and cash equivalents   305    198    65    234 
Cash and cash equivalents at beginning of the year   913    264    913    264 
Effect of exchange rate fluctuations on balances of cash and cash equivalents   43    8    39    11 
Cash and cash equivalents at end of the period   1,261    470    1,261    470 

 

Summary Data from OPC’s Consolidated Statement of Financial Position

 

   As at 
   June 30, 2026   December 31, 2025 
   $ millions 
Total financial liabilities1   2,977    1,769 
Total monetary assets2   1,448    1,077 
Investment in associated companies   1,015    1,626 
Total equity attributable to the owners   2,332    2,028 
Total assets   6,697    4,698 

 

 
1. Including loans from banks and others and debentures
2. Including cash and cash equivalents, term deposits and restricted cash

 

8 

 

Appendix C

 

Definition of OPC’s EBITDA and Adjusted EBITDA including proportionate share of associated companies and non-IFRS reconciliation

 

This press release presents OPC’s Adjusted EBITDA including proportionate share of associated companies, which is a non-IFRS financial measure.

 

OPC’s EBITDA is defined for each period as net profit/(loss) before depreciation and amortization, financing expenses, net, and income tax expense. OPC’s Adjusted EBITDA, including proportionate share of associated companies, is defined as EBITDA as further adjusted for expenses not in the ordinary course of business and/or of a non-recurring nature and share of depreciation and amortization, financing expenses and income tax expenses (if any) of associated companies. EBITDA and Adjusted EBITDA including proportionate share of associated companies are not recognized under IFRS as a measure of financial performance and should not be considered as a substitute for net profit or loss, cash flow from operations or other measures of operating performance determined in accordance with IFRS. EBITDA and Adjusted EBITDA including proportionate share of associated companies are not intended to represent funds available for dividends or other discretionary uses because those funds may be required for debt service, capital expenditures, working capital and other commitments and contingencies. There are limitations that impair the use of EBITDA and Adjusted EBITDA including proportionate share of associated companies as measures of OPC’s profitability since it does not take into consideration certain costs and expenses that result from OPC’s business that could have a significant effect on net profit, such as financial expenses, taxes, and depreciation and amortization.

 

OPC believes that the disclosure of EBITDA and Adjusted EBITDA including proportionate share of associated companies provides useful information to investors and financial analysts in their review of the company’s, its subsidiaries’, and its associated companies’ operating performance and in the comparison of such operating performance to the operating performance of other companies in the same industry or in other industries that have different capital structures, debt levels and/or income tax rates.

 

Set forth below is a reconciliation of OPC’s net profit to EBITDA and Adjusted EBITDA including proportionate share of associated companies for the periods presented. Other companies may calculate EBITDA and Adjusted EBITDA including proportionate share of associated companies differently, and therefore this presentation of EBITDA and Adjusted EBITDA including proportionate share of associated companies may not be comparable to other similarly titled measures used by other companies.

 

  

For the three months ended

June 30,

 
   2026   2025 
   $ millions 
Profit for the period   15    1 
Depreciation and amortization   31    18 
Financing expenses, net   22    20 
Income tax expense   7    - 
EBITDA   75    39 
Share of depreciation and amortization and financing expenses included within share of profit of associated companies, net   45    50 
Changes in net expenses, not in the ordinary course of business and/or of a non-recurring nature   11    1 
Adjusted EBITDA including proportionate share of associated companies   131    90 

 

9